Cargando…
Impact of tofacitinib on patient outcomes in rheumatoid arthritis – review of clinical studies
Rheumatoid arthritis is a chronic, progressive autoimmune disease associated with inflammation and destruction of joints and systemic effects, which result in significant impact on patient’s quality of life and function. Tofacitinib was approved for the treatment of rheumatoid arthritis in the USA i...
Autores principales: | Boyce, Eric G, Vyas, Deepti, Rogan, Edward L, Valle-Oseguera, Cynthia S, O’Dell, Kate M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716749/ https://www.ncbi.nlm.nih.gov/pubmed/26834501 http://dx.doi.org/10.2147/PROM.S62879 |
Ejemplares similares
-
Fracture in clinical studies of tofacitinib in rheumatoid arthritis
por: Hansen, Karen E., et al.
Publicado: (2022) -
Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program
por: Mariette, Xavier, et al.
Publicado: (2018) -
Clinical scenarios-based guide for tofacitinib in rheumatoid arthritis
por: Mortezavi, Mahta, et al.
Publicado: (2023) -
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
por: Clowse, Megan E. B., et al.
Publicado: (2016) -
Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
por: Winthrop, Kevin L, et al.
Publicado: (2014)